By Type-
By Application-
By Health Benefits-
By Ingredients Form-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nutraceutical Ingredients Market Snapshot
Chapter 4. Global Nutraceutical Ingredients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Probiotic
5.2.2. Proteins and amino acids
5.2.3. Phytochemical & plant extracts
5.2.4. Fibers & specialty carbohydrates
5.2.5. Omega 3 fatty acids
5.2.6. Vitamins
5.2.7. Prebiotic
5.2.8. Carotenoids
5.2.9. Minerals
5.2.10. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Food
6.2.2. Beverages
6.2.3. Personal care
6.2.4. Animal nutrition
6.2.5. Dietary supplements
Chapter 7. Market Segmentation 3: by Health Benefits Estimates & Trend Analysis
7.1. by Health Benefits & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Health Benefits:
7.2.1. Cognitive health
7.2.2. Gut health
7.2.3. Heart health
7.2.4. Bone health
7.2.5. Immunity
7.2.6. Nutrition
7.2.7. Weight management
7.2.8. Others
Chapter 8. Market Segmentation 4: by Ingredients Form Estimates & Trend Analysis
8.1. by Ingredients Form & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Ingredients Form:
8.2.1. Dry
8.2.2. Liquid
Chapter 9. Nutraceutical Ingredients Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nutraceutical Ingredients Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.1.2. North America Nutraceutical Ingredients Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.3. North America Nutraceutical Ingredients Market revenue (US$ Million) by Health Benefits, 2021-2034
9.1.4. North America Nutraceutical Ingredients Market revenue (US$ Million) by Ingredients Form, 2021-2034
9.1.5. North America Nutraceutical Ingredients Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Nutraceutical Ingredients Market revenue (US$ Million) by Type, 2021-2034
9.2.2. Europe Nutraceutical Ingredients Market revenue (US$ Million) by Application, 2021-2034
9.2.3. Europe Nutraceutical Ingredients Market revenue (US$ Million) by Health Benefits, 2021-2034
9.2.4. Europe Nutraceutical Ingredients Market revenue (US$ Million) by Ingredients Form, 2021-2034
9.2.5. Europe Nutraceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Nutraceutical Ingredients Market revenue (US$ Million) by Type, 2021-2034
9.3.2. Asia Pacific Nutraceutical Ingredients Market revenue (US$ Million) by Application, 2021-2034
9.3.3. Asia-Pacific Nutraceutical Ingredients Market revenue (US$ Million) by Health Benefits, 2021-2034
9.3.4. Asia-Pacific Nutraceutical Ingredients Market revenue (US$ Million) by Ingredients Form, 2021-2034
9.3.5. Asia Pacific Nutraceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Nutraceutical Ingredients Market revenue (US$ Million) by Type, 2021-2034
9.4.2. Latin America Nutraceutical Ingredients Market revenue (US$ Million) by Application, 2021-2034
9.4.3. Latin America Nutraceutical Ingredients Market revenue (US$ Million) by Health Benefits, 2021-2034
9.4.4. Latin America Nutraceutical Ingredients Market revenue (US$ Million) by Ingredients Form, 2021-2034
9.4.5. Latin America Nutraceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nutraceutical Ingredients Market revenue (US$ Million) by Type, 2021-2034
9.5.2. Middle East & Africa Nutraceutical Ingredients Market revenue (US$ Million) by Application, 2021-2034
9.5.3. Middle East & Africa Nutraceutical Ingredients Market revenue (US$ Million) by Health Benefits, 2021-2034
9.5.4. Middle East & Africa Nutraceutical Ingredients Market revenue (US$ Million) by Ingredients Form, 2021-2034
9.5.5. Middle East & Africa Nutraceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Associated British Foods plc (London)
10.2.2. Arla Foods (Denmark)
10.2.3. Koninklijke DSM N.V.(The Netherlands)
10.2.4. Ingredion Incorporated (U.S.)
10.2.5. Tate & Lyle PLC (U.K.)
10.2.6. Ajinomoto CO. INC. (Japan)
10.2.7. Chr. Hansen Holding A/S (Denmark)
10.2.8. Glanbia PLC (Ireland)
10.2.9. Fonterra Co-operative Group Limited (New Zealand)
10.2.10. Cargill, Incorporated (U.S.)
10.2.11. Archer Daniels Midland Company (U.S.)
10.2.12. DuPont de Nemours, Inc. (U.S.)
10.2.13. BASF SE (Germany)
10.2.14. Kerry Inc. (Ireland)
10.2.15. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.